Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B7c37e637c6ca7887eb42ebd8ee5408a1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B7c37e637c6ca7887eb42ebd8ee5408a1 NCIT_P378 "NCI" @default.
- B7c37e637c6ca7887eb42ebd8ee5408a1 type Axiom @default.
- B7c37e637c6ca7887eb42ebd8ee5408a1 annotatedProperty IAO_0000115 @default.
- B7c37e637c6ca7887eb42ebd8ee5408a1 annotatedSource NCIT_C200460 @default.
- B7c37e637c6ca7887eb42ebd8ee5408a1 annotatedTarget "A preparation of autologous T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) B-cell antigen receptor complex-associated protein beta chain (CD79b; B-cell-specific glycoprotein B29), with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD79b CAR-T cells JV-213 target and bind to CD79b-expressing tumor cells, thereby inducing selective toxicity in CD79b-expressing tumor cells. CD79b, a critical receptor for successful B-cell development and part of the B-cell receptor (BCR) signaling complex, is widely expressed in certain subtypes of B-cell lymphomas." @default.